Crispr Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $157M | 2.4M | 64.81 |
| 2025-06-30 | $139M | 2.9M | 48.64 |
| 2025-03-31 | $71M | 2.1M | 34.03 |
| 2024-12-31 | $79M | 2.0M | 39.36 |
| 2024-09-30 | $33M | 694k | 46.98 |
| 2024-06-30 | $25M | 461k | 54.01 |
| 2024-03-31 | $25M | 360k | 68.16 |
| 2023-12-31 | $24M | 385k | 62.60 |
| 2023-09-30 | $16M | 356k | 45.39 |
| 2023-06-30 | $16M | 282k | 56.14 |
| 2023-03-31 | $12M | 264k | 45.23 |
| 2022-12-31 | $18M | 449k | 40.65 |
| 2022-09-30 | $18M | 268k | 65.35 |
| 2022-06-30 | $14M | 234k | 60.77 |
| 2022-03-31 | $10M | 203k | 50.00 |
| 2021-12-31 | $14M | 190k | 75.78 |
| 2021-09-30 | $16M | 140k | 111.93 |
| 2021-06-30 | $17M | 116k | 150.00 |
| 2021-03-31 | $29M | 238k | 121.85 |
| 2020-12-31 | $20M | 135k | 150.00 |
| 2020-09-30 | $7.8M | 93k | 83.65 |
| 2020-06-30 | $6.2M | 84k | 73.49 |
| 2020-03-31 | $2.9M | 69k | 42.41 |
| 2019-12-31 | $3.6M | 56k | 63.49 |
| 2019-09-30 | $1.9M | 46k | 40.99 |
| 2019-06-30 | $2.7M | 57k | 47.10 |
| 2019-03-31 | $2.0M | 56k | 35.80 |
| 2018-12-31 | $1.5M | 51k | 28.57 |
| 2018-09-30 | $3.6M | 82k | 44.35 |
| 2018-06-30 | $4.8M | 83k | 58.70 |
| 2018-03-31 | $2.7M | 59k | 45.71 |
| 2017-12-31 | $56k | 2.4k | 23.63 |
| 2017-09-30 | $10k | 570 | 17.54 |
| 2017-06-30 | $25k | 1.5k | 16.09 |
| 2017-03-31 | $12k | 570 | 21.05 |
| 2016-12-31 | $82k | 4.0k | 20.33 |